Tevogen Bio Holdings Inc. Warrant (TVGNW)

• Market cap: $8.35M
• 1 day: -8.04%
• 5 days: -14.57%
• 1 month: 8.82%
• 3 months: -47.30%
• 6 months: -14.73%
• Year to date: -21.83%
• 1 year: 17.25%
• 5 years: -89.58%
• 10 years: -89.58%
• Sector: Healthcare
• Industry: Biotechnology

About: Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Employees: 17

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

3% more funds holding

Funds holding: 36 [Q4 2024] → 37 (+1) [Q1 2025]

1.02% less ownership

Funds ownership: 6.6% [Q4 2024] → 5.58% (-1.02%) [Q1 2025]

22% less capital invested

Capital invested by funds: $782K [Q4 2024] → $614K (-$168K) [Q1 2025]

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5